Intenship

Eye Health Landscape Research

Disease Burden, Treatment Trends & Consumer Care Opportunities

Objective

Build a foundational research base on the current eye health landscape — covering disease prevalence, emerging treatment approaches, and next-generation consumer care ingredients — to inform the team’s future product and category planning.

Pillar 1: Eye Disease Landscape

1.1 Epidemiology Overview

• Markets: Globe, CN, US and EU, other regions nice to have
• Identify Top 15 high-prevalence eye conditions
• Data points per condition: definition, how many people affected, crowd characteristics, disease consequences, speed of onset, is it growing or stable, key risk factors

1.2 Unmet Needs — Where Are the Gaps?

• For each condition: can be cured or not? what treatments/prevention methods exist today, what do patients/doctors still struggle with
• What are patients and consumers looking for that isn’t well addressed yet

1.3 What’s New in Treatment

• Emerging approaches gaining attention (e.g., low-dose atropine for myopia control, new dry eye therapies)
• Focus on what the approach is and why it matters, not deep clinical/technical detail
• Which companies or research groups are driving these, and how far along are they

Pillar 2: Consumer Eye Care — Ingredients & Trends

2.1 Next-Generation Ingredients

• What new or trending active ingredients are appearing in consumer eye care products (e.g. otc drugs, supplements) in US,EU and China?
• For each: mechanism behind, what does it claim to do, and is there published research to support it, ingredient source, available market
• Simple rating: strong evidence / some evidence / early-stage only

Final Output

Summary document version

Your ZEISS Recruiting Team